Consensus paper of the WFSBP task force on biological markers: Biological markers in depression

World Journal of Biological Psychiatry

Volumn 8, Issue 3, 2007, Pages 141-174

  Mössner, Rainald ^a   Mikova, Olya ^b   Koutsilieri, Eleni ^a   Saoud, Mohamed ^c,d   Ehlis, Ann Christine ^a   Müller, Norbert ^e   Fallgatter, Andreas J ^a   Riederer, Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c UNIVERSITÉ DE LYON   (France)

^d CENTRE HOSPITALIER LE VINATIER   (France)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

ENGL

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; BIOCHEMICAL MARKER; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLESTEROL; CYANOCOBALAMIN; DESIPRAMINE; DEXAMETHASONE; FLUOXETINE; FOLIC ACID; FOLINIC ACID; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IMIPRAMINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LITHIUM; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NITRIC OXIDE SYNTHASE; NORTRIPTYLINE; PLACEBO; PYRIDOXINE; S ADENOSYLMETHIONINE; SEROTONIN; SEROTONIN 1A RECEPTOR; THIAMINE; TRYPTOPHAN HYDROXYLASE 2; UNINDEXED DRUG; ZINC;

BRAIN BLOOD FLOW; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CONSENSUS DEVELOPMENT; CYANOCOBALAMIN DEFICIENCY; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DRUG DOSE INCREASE; EVENT RELATED POTENTIAL; GENETIC POLYMORPHISM; HAMILTON SCALE; HUMAN; HYPOCHOLESTEROLEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR DEPRESSION; NEUROIMAGING; NEUROPHYSIOLOGY; NEUROPSYCHOLOGY; NONHUMAN; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; PSYCHOTHERAPY; PYRIDOXINE DEFICIENCY; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALIDATION STUDY;

ALGORITHMS; BIOLOGICAL MARKERS; CHOLESTEROL; CONSENSUS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROLYTES; GTP-BINDING PROTEINS; HUMANS; INTERLEUKINS; NERVE GROWTH FACTORS; NITROGEN; RECEPTORS, SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRIGLYCERIDES; VITAMINS;

EID: 34547410247     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701263303     Document Type: Review

References (328)

1. Abou-Saleh, MT and Coppen, A. (1989) Serum and red blood cell folate in depression. Acta Psychiatr Scand, 80, pp. 78-82.
2. Akin, D., Manier, DH, Sanders-Bush, E. and Shelton, RC (2004) Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology, 29, pp. 2081-2087.
3. Akin, D., Manier, DH, Sanders-Bush, E. and Shelton, RC (2005) Signal transduction abnormalities in melancholic depression. Int J Neuropsychopharmacol, 8, pp. 5-16.
4. Alberati-Giani, D., Ricciardi-Castagnoli, P., Kohler, C. and Cesura, AM (1996) Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells. J Neurochem, 66, pp. 996-1004.
5. Alpert, JE, Mischoulon, D., Rubenstein, GE, Bottonari, K., Nierenberg, AA and Fava, M. (2002) Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry, 14, pp. 33-38.
6. Alpert, JE, Papakostas, G. and Mischoulon, D. (2004) S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: An open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol, 24, pp. 661-664.
7. Alpert, M., Silva, RR and Pouget, ER (2003) Prediction of treatment response in geriatric depression from baseline folate level: Interaction with an SSRI or a tricyclic antidepressant. J Clin Psychopharmacol, 23, pp. 309-313.
8. Altar, CA (1999) Neurotrophins and depression. Trends Pharmacol Sci, 20, pp. 59-61.
9. Altar, CA, Whitehead, RE, Chen, R., Wortwein, G. and Madsen, TM (2003) Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry, 54, pp. 703-709.
10. Amsterdam, JD and Hernz, WJ (1993) Serum antibodies to herpes simplex virus types I and II in depressed patients. Biol Psychiatry, 34, pp. 417-420.
11. Anderson, AD, Oquendo, MA, Parsey, RV, Milak, MS, Campbell, C. and Mann, JJ (2004) Regional brain responses to serotonin in major depressive disorder. J Affect Disord, 82, pp. 411-417.
12. Angelucci, F., Aloe, L., Vasquez, PJ and Mathe, AA (2000) Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Neuroreport, 11, pp. 1369-1373.
13. Arango, V., Underwood, MD and Boldrini, M. (2001) Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology, 25, pp. 892-903.
14. Arranz, B., Eriksson, A., Mellerup, E., Plenge, P. and Marcusson, J. (1994) Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol Psychiatry, 35, pp. 457-463.
15. Austin, MP, Mitchell, P. and Wilhelm, K. (1999) Cognitive function in depression: A distinct pattern of frontal impairment in melancholia?. Psychol Med, 29, pp. 73-85.
16. Aydemir, O., Deveci, A. and Taneli, F. (2005) The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: A preliminary study. Prog Neuropsychopharmacol Biol Psychiatry, 29, pp. 261-265.
17. Baccarelli, A., Pesatori, AC and Bertazzi, PA (2000) Occupational and environmental agents as endocrine disruptors: Experimental and human evidence. J Endocrinol Invest, 23, pp. 771-781.
18. Baghai, TC, Schule, C. and Zwanzger, P. (2002) Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. Neurosci Lett, 328, pp. 299-303.
19. Baghai, TC, Binder, EB and Schule, C. (2006) Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry
20. Baudic, S., Tzortzis, C., Barba, GD and Traykov, L. (2004) Executive deficits in elderly patients with major unipolar depression. J Geriatr Psychiatry Neurol, 17, pp. 195-201.
21. Beats, BC, Sahakian, BJ and Levy, R. (1996) Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med, 26, pp. 591-603.
22. Beck, AT, Ward, CH, Mendelson, M., Mock, J. and Erbaugh, J. (1961) An inventory for measuring depression. Arch Gen Psychiatry, 4, pp. 561-571.
23. Bell, IR, Edman, JS and Miller, J. (1990) Relationship of normal serum vitamin B12 and folate levels to cognitive test performance in subtypes of geriatric major depression. J Geriatr Psychiatry Neurol, 3, pp. 98-105.
24. Bell, IR, Edman, JS and Marby, DW (1990) Vitamin B12 and folate status in acute geropsychiatric inpatients: Affective and cognitive characteristics of a vitamin nondeficient population. Biol Psychiatry, 27, pp. 125-137.
25. Bell, IR, Edman, JS and Morrow, FD (1991) B complex vitamin patterns in geriatric and young adult inpatients with major depression. J Am Geriatr Soc, 39, pp. 252-257.
26. Bell, IR, Edman, JS and Morrow, FD (1992) Brief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunction. J Am Coll Nutr, 11, pp. 159-163.
27. Berk, M., Wadee, AA, Kuschke, RH and O'Neill-Kerr, A. (1997) Acute phase proteins in major depression. J Psychosom Res, 43, pp. 529-534.
28. Bhagwagar, Z., Rabiner, EA, Sargent, PA, Grasby, PM and Cowen, PJ. (2004) Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry, 9, pp. 386-392.
29. Binder, EB, Salyakina, D. and Lichtner, P. (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet, 36, pp. 1319-1325.
30. Bittner Jr, AC, Echeverria, D. and Woods, JS (1998) Behavioral effects of low-level exposure to Hg0 among dental professionals: A cross-study evaluation of psychomotor effects. Neurotoxicol Teratol, 20, pp. 429-439.
31. Bjelland, I., Tell, GS, Vollset, SE, Refsum, H. and Ueland, PM. (2003) Folate, vitamin B12, homocysteine, and the MTHFR 677C-> T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Arch Gen Psychiatry, 60, pp. 618-626.
32. Blackwood, DH, Whalley, LJ, Christie, JE, Blackburn, IM, Clair, DM St and McInnes, A. (1987) Changes in auditory P3 event-related potential in schizophrenia and depression. Br J Psychiatry, 150, pp. 154-160.
33. Bonaccorso, S., Lin, AH and Verkerk, R. (1998) Immune markers in fibromyalgia: Comparison with major depressed patients and normal volunteers. J Affect Disord, 48, pp. 75-82.
34. Bondy, B., Baghai, TC and Zill, P. (2002) Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: A possible link to cardiovascular disease?. Mol Psychiatry, 7, pp. 1120-1126.
35. Bonni, A., Brunet, A., West, AE, Datta, SR, Takasu, MA and Greenberg, ME (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science, 286, pp. 1358-1362.
36. Borkowska, A. and Rybakowski, JK (2001) Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Disord, 3, pp. 88-94.
37. Botez, MI, Young, SN, Bachevalier, J. and Gauthier, S. (1982) Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Ann Neurol, 12, pp. 479-484.
38. Bottiglieri, T., Hyland, K. and Laundy, M. (1992) Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med, 22, pp. 871-876.
39. Brambilla, F. and Maggioni, M. (1998) Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand, 97, pp. 309-313.
40. Breier, A., Kelsoe Jr, JR, Kirwin, PD, Beller, SA, Wolkowitz, OM and Pickar, D. (1988) Early parental loss and development of adult psychopathology. Arch Gen Psychiatry, 45, pp. 987-993.
41. Brody, AL, Saxena, S. and Stoessel, P. (2001) Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: Preliminary findings. Arch Gen Psychiatry, 58, pp. 631-640.
42. Burt, T., Prudic, J., Peyser, S., Clark, J. and Sackeim, HA (2000) Learning and memory in bipolar and unipolar major depression: Effects of aging. Neuropsychiatry Neuropsychol Behav Neurol, 13, pp. 246-253.
43. Calabrese, JR, Skwerer, RG and Barna, B. (1986) Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res, 17, pp. 41-47.
44. Calev, A., Korin, Y., Shapira, B., Kugelmass, S. and Lerer, B. (1986) Verbal and non-verbal recall by depressed and euthymic affective patients. Psychol Med, 16, pp. 789-794.
45. Carney, MW, Chary, TK and Laundy, M. (1990) Red cell folate concentrations in psychiatric patients. J Affect Disord, 19, pp. 207-213.
46. Channon, S., Baker, JE and Robertson, MM (1993) Effects of structure and clustering on recall and recognition memory in clinical depression. J Abnorm Psychol, 102, pp. 323-326.
47. Chen, AC, Shirayama, Y., Shin, KH, Neve, RL and Duman, RS (2001) Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry, 49, pp. 753-762.
48. Chen, B., Dowlatshahi, D., MacQueen, GM, Wang, JF and Young, LT (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry, 50, pp. 260-265.
49. Chen, DF and Tonegawa, S. (1998) Why do mature CNS neurons of mammals fail to re-establish connections following injury-functions of bcl-2. Cell Death Differ, 5, pp. 816-822.
50. Chen, DF, Schneider, GE, Martinou, JC and Tonegawa, S. (1997) Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature, 385, pp. 434-439.
51. Chen, G., Rajkowska, G., Seraji-Bozorgzad, N. and Manji, HK (2000) Enhancement of hippocampal neurogenesis by lithium. J Neurochem, 75, pp. 1729-1734.
52. Chetty, CS, McBride, V., Sands, S. and Rajanna, B. (1990) Effects in vitro of mercury on rat brain Mg(+ +) -ATPase. Arch Int Physiol Biochim, 98, pp. 261-267.
53. Choi, MJ, Lee, HJ, Ham, BJ, Cha, JH, Ryu, SH and Lee, MS (2004) Association between major depressive disorder and the -1438A/G polymorphism of the serotonin 2A receptor gene. Neuropsychobiology, 49, pp. 38-41.
54. Chrapko, WE, Jurasz, P., Radomski, MW, Lara, N., Archer, SL and Melledo, JM Le (2004) Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol Psychiatry, 56, pp. 129-134.
55. Claes, S., Villafuerte, S. and Forsgren, T. (2003) The corticotropin-releasing hormone binding protein is associated with major depression in a population from Northern Sweden. Biol Psychiatry, 54, pp. 867-872.
56. Coppen, A. and Bailey, J. (2000) Enhancement of the antidepressant action of fluoxetine by folic acid: A randomised, placebo controlled trial. J Affect Disord, 60, pp. 121-130.
57. Cotman, CW and Berchtold, NC. (2002) Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci, 25, pp. 295-301.
58. Coyle, JT and Schwarcz, R. (2000) Mind glue: Implications of glial cell biology for psychiatry. Arch Gen Psychiatry, 57, pp. 90-93.
59. Crook, WG. (1984) Depression associated with Candida albicans infections. Jama, 251, pp. 2928-2929.
60. D'Sa, C. and Duman, RS (2002) Antidepressants and neuroplasticity. Bipolar Disord, 4, pp. 183-194.
61. Danion, JM, Kauffmann-Muller, F., Grange, D., Zimmermann, MA and Greth, P. (1995) Affective valence of words, explicit and implicit memory in clinical depression. J Affect Disord, 34, pp. 227-234.
62. Davidson, RJ (1998) Anterior electrophysiological asymmetries, emotion, and depression: Conceptual and methodological conundrums. Psychophysiology, 35, pp. 607-614.
63. Drevets, WC (2001) Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol, 11, pp. 240-249.
64. Drevets, WC, Frank, E., Price, JC, Kupfer, DJ, Greer, PJ and Mathis, C. (2000) Serotonin type-1A receptor imaging in depression. Nucl Med Biol, 27, pp. 499-507.
65. Duch, DS, Woolf, JH, Nichol, CA, Davidson, JR and Garbutt, JC (1984) Urinary excretion of biopterin and neopterin in psychiatric disorders. Psychiatry Res, 11, pp. 83-89.
66. Duman, RS and Vaidya, VA (1998) Molecular and cellular actions of chronic electroconvulsive seizures. J Ect, 14, pp. 181-193.
67. Duman, RS, Malberg, J. and Thome, J. (1999) Neural plasticity to stress and antidepressant treatment. Biol Psychiatry, 46, pp. 1181-1191.
68. Duman, RS, Malberg, J. and Nakagawa, S. (2001) Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther, 299, pp. 401-407.
69. Dunbar, PR, Hill, J., Neale, TJ and Mellsop, GW (1992) Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychol Med, 22, pp. 1051-1057.
70. Dwivedi, Y., Rizavi, HS, Conley, RR, Roberts, RC, Tamminga, CA and Pandey, GN (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry, 60, pp. 804-815.
71. Dwivedi, Y., Rao, JS and Rizavi, HS (2003) Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry, 60, pp. 273-282.
72. Echeverria, D., Aposhian, HV and Woods, JS (1998) Neurobehavioral effects from exposure to dental amalgam Hg(o): New distinctions between recent exposure and Hg body burden. Faseb J, 12, pp. 971-980.
73. Edwards, DA (1985) Depression and Candida. J Am Med Assoc, 253, p. 3400.
74. Egan, MF, Kojima, M. and Callicott, JH (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112, pp. 257-269.
75. Elliott, R., Sahakian, BJ, Michael, A., Paykel, ES and Dolan, RJ (1998) Abnormal neural response to feedback on planning and guessing tasks in patients with unipolar depression. Psychol Med, 28, pp. 559-571.
76. Elliott, R., Sahakian, BJ, McKay, AP, Herrod, JJ, Robbins, TW and Paykel, ES (1996) Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance. Psychol Med, 26, pp. 975-989.
77. Ellis, PM and Salmond, C. (1994) Is platelet imipramine binding reduced in depression? A meta-analysis. Biol Psychiatry, 36, pp. 292-299.
78. Ershler, WB, Sun, WH and Binkley, N. (1993) Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res, 12, pp. 225-230.
79. Evans, SJ, Choudary, PV and Neal, CR (2004) Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA, 101, pp. 15506-15511.
80. Exton, MS, Artz, M., Siffert, W. and Schedlowski, M. (2003) G protein beta3 subunit 825T allele is associated with depression in young, healthy subjects. Neuroreport, 14, pp. 531-533.
81. Falkenstein, M., Hoormann, J. and Hohnsbein, J. (1997) Event-related potential components related to errors]. Z Exp Psychol, 44, pp. 117-138.
82. Fallgatter, AJ and Strik, WK (1999) The NoGo-anteriorization as a neurophysiological standard-index for cognitive response control. Int J Psychophysiol, 32, pp. 233-238.
83. Fallgatter, AJ, Brandeis, D. and Strik, WK (1997) A robust assessment of the NoGo-anteriorisation of P300 microstates in a cued Continuous Performance Test. Brain Topogr, 9, pp. 295-302.
84. Fallgatter, AJ, Mueller, TJ and Strik, WK (1999) Age-related changes in the brain electrical correlates of response control. Clin Neurophysiol, 110, pp. 833-838.
85. Fallgatter, AJ, Bartsch, AJ and Herrmann, MJ (2002) Electrophysiological measurements of anterior cingulate function. J Neural Transm, 109, pp. 977-988.
86. Fallgatter, AJ, Esienack, SS, Neuhauser, B., Aranda, D., Scheuerpflug, P. and Herrmann, MJ (2000) Stability of late event-related potentials: topographical descriptors of motor control compared with the P300 amplitude. Brain Topogr, 12, pp. 255-261.
87. Fallgatter, AJ, Bartsch, AJ and Strik, WK (2001) Test-retest reliability of electrophysiological parameters related to cognitive motor control. Clin Neurophysiol, 112, pp. 198-204.
88. Fava, M., Borus, JS, Alpert, JE, Nierenberg, AA, Rosenbaum, JF and Bottiglieri, T. (1997) Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry, 154, pp. 426-428.
89. Fehr, C., Grintschuk, N. and Szegedi, A. (2000) The HTR1B 861G > C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy. Psychiatry Res, 97, pp. 1-10.
90. Fernstrom, JD (1977) Effects on the diet on brain neurotransmitters. Metabolism, 26, pp. 207-223.
91. Freedman, DA (1981) The effects of sensory and other deficits in children on their experience of people. J Am Psychoanal Assoc, 29, pp. 831-867.
92. Freitas, AJ, Rocha, JB, Wolosker, H. and Souza, DO (1996) Effects of Hg2+ and CH3Hg+ on Ca2+ fluxes in rat brain microsomes. Brain Res, 738, pp. 257-264.
93. Friedland, RP, Fritsch, T. and Smyth, KA (2001) Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc Natl Acad Sci USA, 98, pp. 3440-3445.
94. Frisch, A., Postilnick, D. and Rockah, R. (1999) Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol Psychiatry, 4, pp. 389-392.
95. Frommberger, UH, Bauer, J., Haselbauer, P., Fraulin, A., Riemann, D. and Berger, M. (1997) Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci, 247, pp. 228-233.
96. Fu, CH, Williams, SC and Cleare, AJ (2004) Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry, 61, pp. 877-889.
97. Gale, CR and Martyn, CN (2004) Birth weight and later risk of depression in a national birth cohort. Br J Psychiatry, 184, pp. 28-33.
98. Garcia, C., Chen, MJ, Garza, AA, Cotman, CW and Russo-Neustadt, A. (2003) The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity. Neuroscience, 119, pp. 721-732.
99. Garcia, R. (2002) Stress, metaplasticity, and antidepressants. Curr Mol Med, 2, pp. 629-638.
100. Gervasoni, N., Aubry, JM and Bondolfi, G. (2005) Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology, 51, pp. 234-238.
101. Glueck, CJ, Tieger, M. and Kunkel, R. (1993) Improvement in symptoms of depression and in an index of life stressors accompany treatment of severe hypertriglyceridemia. Biol Psychiatry, 34, pp. 240-252.
102. Goldberg, TE, Gold, JM and Greenberg, R. (1993) Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry, 150, pp. 1355-1362.
103. Gonul, AS, Akdeniz, F., Taneli, F., Donat, O., Eker, C. and Vahip, S. (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci, 255, pp. 381-386.
104. Grant, MM, Thase, ME and Sweeney, JA (2001) Cognitive disturbance in outpatient depressed younger adults: Evidence of modest impairment. Biol Psychiatry, 50, pp. 35-43.
105. Gultepe, M., Ozcan, O., Avsar, K., Cetin, M., Ozdemir, AS and Gok, M. (2003) Urine methylmalonic acid measurements for the assessment of cobalamin deficiency related to neuropsychiatric disorders. Clin Biochem, 36, pp. 275-282.
106. Gurevich, I., Tamir, H., Arango, V., Dwork, AJ, Mann, JJ and Schmauss, C. (2002) Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron, 34, pp. 349-356.
107. Haack, M., Hinze-Selch, D. and Fenzel, T. (1999) Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis. J Psychiatr Res, 33, pp. 407-418.
108. Haggerty Jr, JJ, Simon, JS, Evans, DL and Nemeroff, CB (1987) Relationship of serum TSH concentration and antithyroid antibodies to diagnosis and DST response in psychiatric inpatients. Am J Psychiatry, 144, pp. 1491-1493.
109. Hamilton, M. (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol, 6, pp. 278-296.
110. Hartmann, M., Heumann, R. and Lessmann, V. (2001) Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J, 20, pp. 5887-5897.
111. Harvey, PO, Bastard, G Le and Pochon, JB (2004) Executive functions and updating of the contents of working memory in unipolar depression. J Psychiatr Res, 38, pp. 567-576.
112. Hashimoto, K., Shimizu, E. and Iyo, M. (2004) Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev, 45, pp. 104-114.
113. Hegerl, U., Gallinat, J. and Juckel, G. (2001) Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?. J Affect Disord, 62, pp. 93-100.
114. Herbert, TB and Cohen, S. (1993) Depression and immunity: A meta-analytic review. Psychol Bull, 113, pp. 472-486.
115. Herran, A., Garcia-Unzueta, MT, Amado, JA, Lopez-Cordovilla, JJ, Diez-Manrique, JF and Vazquez-Barquero, JL (1999) Folate levels in psychiatric outpatients. Psychiatry Clin Neurosci, 53, pp. 531-533.
116. Herrmann, MJ, Weijers, HG, Wiesbeck, GA, Boning, J. and Fallgatter, AJ (2001) Alcohol cue-reactivity in heavy and light social drinkers as revealed by event-related potentials. Alcohol Alcohol, 36, pp. 588-593.
117. Herrmann, MJ, Rommler, J., Ehlis, AC, Heidrich, A. and Fallgatter, AJ (2004) Source localization (LORETA) of the error-related-negativity (ERN/ Ne) and positivity (Pe). Brain Res Cogn Brain Res, 20, pp. 294-299.
118. Hill, SK, Keshavan, MS, Thase, ME and Sweeney, JA (2004) Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Am J Psychiatry, 161, pp. 996-1003.
119. Hintikka, J., Tolmunen, T., Tanskanen, A. and Viinamaki, H. (2003) High vitamin B12 level and good treatment outcome may be associated in major depressive disorder. BMC Psychiatry, 3, p. 17.
120. Holm, KH, Cicchetti, F. and Bjorklund, L. (2001) Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum. Neuroscience, 104, pp. 397-405.
121. Holmes, C., Arranz, M., Collier, D., Powell, J. and Lovestone, S. (2003) Depression in Alzheimer's disease: The effect of serotonin receptor gene variation. Am J Med Genet B Neuropsychiatr Genet, 119, pp. 40-43.
122. Hong, CJ, Tsai, SJ, Cheng, CY, Liao, WY, Song, HL and Lai, HC (1999) Association analysis of the 5-HT(6) receptor polymorphism (C267T) in mood disorders. Am J Med Genet, 88, pp. 601-602.
123. Hsieh, MH, McQuoid, DR, Levy, RM, Payne, ME, MacFall, JR and Steffens, DC (2002) Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry, 17, pp. 519-525.
124. Hua, MS, Huang, CC and Yang, YJ (1996) Chronic elemental mercury intoxication: Neuropsychological follow-up case study. Brain Inj, 10, pp. 377-384.
125. Huang, YY, Grailhe, R., Arango, V., Hen, R. and Mann, JJ (1999) Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology, 21, pp. 238-246.
126. Hvas, AM, Juul, S., Bech, P. and Nexo, E. (2004) Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom, 73, pp. 340-343.
127. Hvas, AM, Juul, S., Lauritzen, L., Nexo, E. and Ellegaard, J. (2004) No effect of vitamin B-12 treatment on cognitive function and depression: A randomized placebo controlled study. J Affect Disord, 81, pp. 269-273.
128. Ibanez, CF (1995) Neurotrophic factors: From structure-function studies to designing effective therapeutics. Trends Biotechnol, 13, pp. 217-227.
129. Ilonen, T., Taiminen, T. and Lauerma, H. (2000) Impaired Wisconsin card sorting test performance in first-episode schizophrenia: Resource or motivation deficit?. Compr Psychiatry, 41, pp. 385-391.
130. Ilsley, JE, Moffoot, AP and O'Carroll, RE (1995) An analysis of memory dysfunction in major depression. J Affect Disord, 35, pp. 1-9.
131. Ivy, AS, Rodriguez, FG, Garcia, C., Chen, MJ and Russo-Neustadt, AA (2003) Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav, 75, pp. 81-88.
132. Iwamoto, K. and Kato, T. (2003) RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett, 346, pp. 169-172.
133. Jacobs, BL, Praag, H. and Gage, FH (2000) Adult brain neurogenesis and psychiatry: A novel theory of depression. Mol Psychiatry, 5, pp. 262-269.
134. Joyce, PR and Paykel, ES (1989) Predictors of drug response in depression. Arch Gen Psychiatry, 46, pp. 89-99.
135. Joyce, PR, Mulder, RT and Luty, SE (2003) Age-dependent antidepressant pharmacogenomics: Polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharmacol, 6, pp. 339-346.
136. Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G. and Aubry, JM (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res, 109, pp. 143-148.
137. Karege, F., Bondolfi, G., Gervasoni, N., Schwald, M., Aubry, JM and Bertschy, G. (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry, 57, pp. 1068-1072.
138. Katila, H., Cantell, K., Hirvonen, S. and Rimon, R. (1989) Production of interferon-alpha and gamma by leukocytes from patients with schizophrenia. Schizophr Res, 2, pp. 361-365.
139. Kaufman, J. (1991) Depressive disorders in maltreated children. J Am Acad Child Adolesc Psychiatry, 30, pp. 257-265.
140. Kawasaki, T., Tanaka, S., Wang, J., Hokama, H. and Hiramatsu, K. (2004) Abnormalities of P300 cortical current density in unmedicated depressed patients revealed by LORETA analysis of event-related potentials. Psychiatry Clin Neurosci, 58, pp. 68-75.
141. Kempermann, G. (2002) Regulation of adult hippocampal neurogenesis-implications for novel theories of major depression. Bipolar Disord, 4, pp. 17-33.
142. Kessing, LV (1998) Cognitive impairment in the euthymic phase of affective disorder. Psychol Med, 28, pp. 1027-1038.
143. Khait, VD, Huang, YY and Zalsman, G. (2005) Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects. Neuropsychopharmacology, 30, pp. 166-172.
144. Kishi, R., Doi, R. and Fukuchi, Y. (1994) Residual neurobehavioural effects associated with chronic exposure to mercury vapour. Occup Environ Med, 51, pp. 35-41.
145. Koch, JM, Kell, S., Hinze-Selch, D. and Aldenhoff, JB (2002) Changes in CREB-phosphorylation during recovery from major depression. J Psychiatr Res, 36, pp. 369-375.
146. Köks, S., Nikopensius, T. and Koido, K. (2006) Analysis of SNP profiles in patients with major depressive disorder. Int J Neuropsychopharmacol, 9, pp. 167-174.
147. Lai, IC, Hong, CJ and Tsai, SJ (2003) Expression of cAMP response element-binding protein in major depression before and after antidepressant treatment. Neuropsychobiology, 48, pp. 182-185.
148. Landro, NI, Stiles, TC and Sletvold, H. (2001) Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry Neuropsychol Behav Neurol, 14, pp. 233-240.
149. Lang, UE, Hellweg, R. and Gallinat, J. (2004) BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology, 29, pp. 795-798.
150. Lauder, JM (1988) Neurotransmitters as morphogens. Prog Brain Res, 73, pp. 365-387.
151. Laurin, D., Verreault, R., Lindsay, J., MacPherson, K. and Rockwood, K. (2001) Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol, 58, pp. 498-504.
152. Lee, BH, Lee, SW and Yoon, D. (2006) Increased plasma nitric oxide metabolites in suicide attempters. Neuropsychobiology, 53, pp. 127-132.
153. Lee, HJ, Cha, JH and Ham, BJ (2004) Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J, 4, pp. 29-33.
154. Lee, S., Wing, YK and Fong, S. (1998) A controlled study of folate levels in Chinese inpatients with major depression in Hong Kong. J Affect Disord, 49, pp. 73-77.
155. Lee, SH, Lee, KJ, Lee, HJ, Ham, BJ, Ryu, SH and Lee, MS (2005) Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder. Psychiatry Clin Neurosci, 59, pp. 140-145.
156. LeMay, LG, Vander, AJ and Kluger, MJ (1990) The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav, 47, pp. 957-961.
157. Lemonde, S., Turecki, G. and Bakish, D. (2003) Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci, 23, pp. 8788-8799.
158. Lerer, B., Macciardi, F. and Segman, RH (2001) Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry, 6, pp. 579-585.
159. Levine, J., Barak, Y., Chengappa, KR, Rapoport, A., Antelman, SM and Barak, V. (1999) Low CSF soluble interleukin 2 receptor levels in acute depression. Short communication. J Neural Transm, 106, pp. 1011-1015.
160. Levinson, DF (2005) Meta-analysis in psychiatric genetics. Curr Psychiatry Rep, 7, pp. 143-151.
161. Levitt, AJ and Joffe, RT (1989) Folate, B12, and life course of depressive illness. Biol Psychiatry, 25, pp. 867-872.
162. Linka, T., Muller, BW, Bender, S. and Sartory, G. (2004) The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. Neurosci Lett, 367, pp. 375-378.
163. Linnoila, M., Whorton, AR, Rubinow, DR, Cowdry, RW, Ninan, PT and Waters, RN (1983) CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry, 40, pp. 405-406.
164. Lipton, ED (1970) A perceptual-motor development program's effect on visual perception and reading readiness of first-grade children. Res Q, 41, pp. 402-405.
165. Liu, SK, Chiu, CH, Chang, CJ, Hwang, TJ, Hwu, HG and Chen, WJ (2002) Deficits in sustained attention in schizophrenia and affective disorders: Stable versus state-dependent markers. Am J Psychiatry, 159, pp. 975-982.
166. Lopez-Figueroa, AL, Norton, CS and Lopez-Figueroa, MO (2004) Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry, 55, pp. 225-233.
167. Lowther, S., Katona, CL, Crompton, MR and Horton, RW (1997) 5-HT1D and 5-HT1E/1F binding sites in depressed suicides: Increased 5-HT1D binding in globus pallidus but not cortex. Mol Psychiatry, 2, pp. 314-321.
168. Lowther, S., De Paermentier, F., Cheetham, SC, Crompton, MR, Katona, CL and Horton, RW (1997) 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J Affect Disord, 42, pp. 199-207.
169. (2003) BDNF and activity-dependent synaptic modulation. Learn Mem, 10, pp. 86-98.
170. MacQueen, GM, Campbell, S. and McEwen, BS (2003) Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA, 100, pp. 1387-1392.
171. Maes, M., Meltzer, HY, Buckley, P. and Bosmans, E. (1995) Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression. Eur Arch Psychiatry Clin Neurosci, 244, pp. 325-329.
172. Maes, M., Bosmans, E., Suy, E., Vandervorst, C., Dejonckheere, C. and Raus, J. (1991) Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. J Affect Disord, 21, pp. 133-140.
173. Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E. and Neels, H. (1997) Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine, 9, pp. 853-858.
174. Maes, M., Stevens, W. and DeClerck, L. (1992) Immune disorders in depression: Higher T helper/T suppressor-cytotoxic cell ratio. Acta Psychiatr Scand, 86, pp. 423-431.
175. Maes, M., Scharpe, S. and Meltzer, HY (1993) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res, 49, pp. 11-27.
176. Maes, M., Meltzer, HY and Bosmans, E. (1995) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord, 34, pp. 301-309.
177. Maes, M., Scharpe, S. and Meltzer, HY (1994) Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response. Psychiatry Res, 54, pp. 143-160.
178. Maes, M., Vandoolaeghe, E. and Neels, H. (1997) Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry, 42, pp. 349-358.
179. Malberg, JE, Eisch, AJ, Nestler, EJ and Duman, RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci, 20, pp. 9104-9110.
180. Mamounas, LA, Blue, ME, Siuciak, JA and Altar, CA (1995) Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci, 15, pp. 7929-7939.
181. Manev, H., Smalheiser, NR and Manev, R. (2001) Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur J Pharmacol, 411, pp. 67-70.
182. Manji, HK, Drevets, WC and Charney, DS (2001) The cellular neurobiology of depression. Nat Med, 7, pp. 541-547.
183. Manji, HK, Quiroz, JA and Sporn, J. (2003) Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry, 53, pp. 707-742.
184. Manzo, L., Artigas, F. and Martinez, E. (1996) Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Hum Exp Toxicol, 15, p. S20.
185. Martin, SD, Martin, E., Rai, SS, Richardson, MA and Royall, R. (2001) Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: Preliminary findings. Arch Gen Psychiatry, 58, pp. 641-648.
186. Martinez, A., Alcantara, S., Borrell, V., Rio, JA Del, Blasi, J. and Otal, R. (1998) TrkB and TrkC signaling are required for maturation and synaptogenesis of hippocampal connections. J Neurosci, 18, pp. 7336-7350.
187. Mathieson, PW (1995) Mercury: God of Th2 cells?. Clin Exp Immunol, 102, pp. 229-230.
188. Mattson, MP and Shea, TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci, 26, pp. 137-146.
189. Mattson, MP, Maudsley, S. and Martin, B. (2004) BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci, 27, pp. 589-594.
190. Mayberg, HS, Brannan, SK and Mahurin, RK (1997) Cingulate function in depression: A potential predictor of treatment response. Neuroreport, 8, pp. 1057-1061.
191. Mellor, AL and Munn, DH (1999) Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation?. Immunol Today, 20, pp. 469-473.
192. Meltzer, CC, Price, JC and Mathis, CA (2004) Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology, 29, pp. 2258-2265.
193. Mendlovic, S., Mozes, E. and Eilat, E. (1999) Immune activation in non-treated suicidal major depression. Immunol Lett, 67, pp. 105-108.
194. Meyer, JH, Ginovart, N. and Boovariwala, A. (2006) Elevated monoamine oxidase a levels in the brain: An explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry, 63, pp. 1209-1216.
195. Minov, C., Baghai, TC and Schule, C. (2001) Serotonin-2A-receptor and -transporter polymorphisms: Lack of association in patients with major depression. Neurosci Lett, 303, pp. 119-122.
196. Miyahara, S., Komori, T. and Fujiwara, R. (2000) Effects of repeated stress on expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat hypothalamus and midbrain. Life Sci, 66, p. PL93.
197. Molnar, M., Potkin, SG, Bunney, WE and Jones, EG (2003) MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients. Biol Psychiatry, 53, pp. 39-47.
198. Moore, GJ, Bebchuk, JM and Hasanat, K. (2000) Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects?. Biol Psychiatry, 48, pp. 1-8.
199. Morcuende, S., Gadd, CA and Peters, M. (2003) Increased neurogenesis and brain-derived neurotrophic factor in neurokinin-1 receptor gene knockout mice. Eur J Neurosci, 18, pp. 1828-1836.
200. Moritz, S., Birkner, C. and Kloss, M. (2002) Executive functioning in obsessive-compulsive disorder, unipolar depression, and schizophrenia. Arch Clin Neuropsychol, 17, pp. 477-483.
201. Mössner, R., Walitza, S. and Geller, F. (2006) Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol, 9, pp. 437-442.
202. Müller, MB, Toschi, N., Kresse, AE, Post, A. and Keck, ME (2000) Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology, 23, pp. 205-215.
203. Müller, N., Hofschuster, E., Ackenheil, M., Mempel, W. and Eckstein, R. (1993) Investigations of the cellular immunity during depression and the free interval: Evidence for an immune activation in affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry, 17, pp. 713-730.
204. Munn, DH, Shafizadeh, E., Attwood, JT, Bondarev, I., Pashine, A. and Mellor, AL (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med, 189, pp. 1363-1372.
205. Murphy, FC, Rubinsztein, JS and Michael, A. (2001) Decision-making cognition in mania and depression. Psychol Med, 31, pp. 679-693.
206. Naber, CK, Husing, J., Wolfhard, U., Erbel, R. and Siffert, W. (2000) Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction. Hypertension, 36, pp. 986-989.
207. Nakagawa, S., Kim, JE and Lee, R. (2002) Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci, 22, pp. 3673-3682.
208. Naylor, GJ, Smith, AH, Bryce-Smith, D. and Ward, NI (1984) Elevated vanadium content of hair and mania. Biol Psychiatry, 19, pp. 759-764.
209. Neu, P., Kiesslinger, U., Schlattmann, P. and Reischies, FM (2001) Time-related cognitive deficiency in four different types of depression. Psychiatry Res, 103, pp. 237-247.
210. Neu, P., Bajbouj, M., Schilling, A., Godemann, F., Berman, RM and Schlattmann, P. (2005) Cognitive function over the treatment course of depression in middle-aged patients: Correlation with brain MRI signal hyperintensities. J Psychiatr Res, 39, pp. 129-135.
211. Neves-Pereira, M., Mundo, E., Muglia, P., King, N., Macciardi, F. and Kennedy, JL (2002) The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study. Am J Hum Genet, 71, pp. 651-655.
212. Newton, SS, Thome, J. and Wallace, TL (2002) Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci, 22, pp. 10883-10890.
213. Nibuya, M., Morinobu, S. and Duman, RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci, 15, pp. 7539-7547.
214. Nibuya, M., Nestler, EJ and Duman, RS (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci, 16, pp. 2365-2372.
215. Nibuya, M., Takahashi, M., Russell, DS and Duman, RS (1999) Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett, 267, pp. 81-84.
216. Nishino, S., Ueno, R., Ohishi, K., Sakai, T. and Hayaishi, O. (1989) Salivary prostaglandin concentrations: Possible state indicators for major depression. Am J Psychiatry, 146, pp. 365-368.
217. Niswender, CM, Herrick-Davis, K. and Dilley, GE (2001) RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology, 24, pp. 478-491.
218. Nonaka, S., Katsube, N. and Chuang, DM (1998) Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther, 286, pp. 539-547.
219. Ohishi, K., Ueno, R., Nishino, S., Sakai, T. and Hayaishi, O. (1988) Increased level of salivary prostaglandins in patients with major depression. Biol Psychiatry, 23, pp. 326-334.
220. Oliff, HS, Berchtold, NC, Isackson, P. and Cotman, CW (1998) Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res Mol Brain Res, 61, pp. 147-153.
221. Ongur, D. and Price, JL (1998) Prefrontal cortical projections to the hypothalamus in macaque monkeys. J Comp Neurol, 401, pp. 480-505.
222. Oswald, P., Souery, D. and Massat, I. (2003) Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study. Eur Neuropsychopharmacol, 13, pp. 365-368.
223. Papakostas, GI, Petersen, T. and Mischoulon, D. (2004) Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy. J Clin Psychiatry, 65, pp. 1096-1098.
224. Papakostas, GI, Petersen, T. and Mischoulon, D. (2004) Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry, 65, pp. 1090-1095.
225. Paradiso, S., Lamberty, GJ, Garvey, MJ and Robinson, RG (1997) Cognitive impairment in the euthymic phase of chronic unipolar depression. J Nerv Ment Dis, 185, pp. 748-754.
226. Pascual-Marqui, RD, Michel, CM and Lehmann, D. (1994) Low resolution electromagnetic tomography: A new method for localizing electrical activity in the brain. Int J Psychophysiol, 18, pp. 49-65.
227. Penninx, BW, Guralnik, JM, Ferrucci, L., Fried, LP, Allen, RH and Stabler, SP (2000) Vitamin B(12) deficiency and depression in physically disabled older women: Epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry, 157, pp. 715-721.
228. Perlingeiro, RC and Queiroz, ML (1994) Polymorphonuclear phagocytosis and killing in workers exposed to inorganic mercury. Int J Immunopharmacol, 16, pp. 1011-1017.
229. Perry, BD and Pollard, R. (1998) Homeostasis, stress, trauma, and adaptation. A neurodevelopmental view of childhood trauma. Child Adolesc Psychiatr Clin N Am, 7, pp. 33-51.
230. Pettmann, B. and Henderson, CE (1998) Neuronal cell death. Neuron, 20, pp. 633-647.
231. Pfefferbaum, A., Ford, JM, Wenegrat, BG, Roth, WT and Kopell, BS (1984) Clinical application of the P3 component of event-related potentials. I. Normal aging. Electroencephalogr Clin Neurophysiol, 59, pp. 85-103.
232. Pizzagalli, D., Pascual-Marqui, RD and Nitschke, JB (2001) Anterior cingulate activity as a predictor of degree of treatment response in major depression: Evidence from brain electrical tomography analysis. Am J Psychiatry, 158, pp. 405-415.
233. Plata-Salaman, CR (1991) Immunoregulators in the nervous system. Neurosci Biobehav Rev, 15, pp. 185-215.
234. Polich, J. and Herbst, KL (2000) P300 as a clinical assay: Rationale, evaluation, and findings. Int J Psychophysiol, 38, pp. 3-19.
235. Poo, MM (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci, 2, pp. 24-32.
236. Porter, RJ, Gallagher, P., Thompson, JM and Young, AH (2003) Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry, 182, pp. 214-220.
237. Pozzo-Miller, LD, Gottschalk, W. and Zhang, L. (1999) Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci, 19, pp. 4972-4983.
238. Procter, A. (1991) Enhancement of recovery from psychiatric illness by methylfolate. Br J Psychiatry, 159, pp. 271-272.
239. Provence, S. (1983) Struggling against deprivation and trauma. A longitudinal case study. Psychoanal Study Child, 38, pp. 233-256.
240. Rabiner, EA, Bhagwagar, Z., Gunn, RN, Cowen, PJ and Grasby, PM (2004) Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: Effect of treatment or an endophenotype of depression?. Neuropsychopharmacology, 29, pp. 1688-1698.
241. Rafter, D. (2001) Biochemical markers of anxiety and depression. Psychiatry Res, 103, pp. 93-96.
242. Rajanna, B., Chetty, CS, Rajanna, S., Hall, E., Fail, S. and Yallapragada, PR (1995) Modulation of protein kinase C by heavy metals. Toxicol Lett, 81, pp. 197-203.
243. Rajkowska, G. (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry, 48, pp. 766-777.
244. Ramos, MI, Allen, LH, Haan, MN, Green, R. and Miller, JW (2004) Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin Nutr, 80, pp. 1024-1028.
245. Rasmussen, HH, Mortensen, PB and Jensen, IW (1989) Depression and magnesium deficiency. Int J Psychiatry Med, 19, pp. 57-63.
246. Ravnkilde, B., Videbech, P., Clemmensen, K., Egander, A., Rasmussen, NA and Rosenberg, R. (2002) Cognitive deficits in major depression. Scand J Psychol, 43, pp. 239-251.
247. Reid, IC and Stewart, CA (2001) How antidepressants work: New perspectives on the pathophysiology of depressive disorder. Br J Psychiatry, 178, pp. 299-303.
248. Reif, A., Strobel, A. and Jacob, CP (2006) A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder. Int J Neuropsychopharmacol, 9, pp. 13-20.
249. Reivich, M., Amsterdam, JD, Brunswick, DJ and Shiue, CY (2004) PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression. J Affect Disord, 82, pp. 321-327.
250. Riccio, A., Ahn, S., Davenport, CM, Blendy, JA and Ginty, DD (1999) Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science, 286, pp. 2358-2361.
251. Rogers, MA, Bellgrove, MA, Chiu, E., Mileshkin, C. and Bradshaw, JL (2004) Response selection deficits in melancholic but not nonmelancholic unipolar major depression. J Clin Exp Neuropsychol, 26, pp. 169-179.
252. Rosel, P., Arranz, B., Urretavizcaya, M., Oros, M., San, L. and Navarro, MA (2004) Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims. Neuropsychobiology, 49, pp. 189-195.
253. Ross, BM, Ward, P. and Glen, I. (2004) Delayed vasodilatory response to methylnicotinate in patients with unipolar depressive disorder. J Affect Disord, 82, pp. 285-290.
254. Rossi, AD, Larsson, O. and Manzo, L. (1993) Modifications of Ca2+ signaling by inorganic mercury in PC12 cells. Faseb J, 7, pp. 1507-1514.
255. Roth, WT, Pfefferbaum, A., Kelly, AF, Berger, PA and Kopell, BS (1981) Auditory event-related potentials in schizophrenia and depression. Psychiatry Res, 4, pp. 199-212.
256. Rothermundt, M., Arolt, V., Fenker, J., Gutbrodt, H., Peters, M. and Kirchner, H. (2001) Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci, 251, pp. 90-97.
257. Roy, A., Pickar, D., Paul, S., Doran, A., Chrousos, GP and Gold, PW (1987) CSF corticotropin-releasing hormone in depressed patients and normal control subjects. Am J Psychiatry, 144, pp. 641-645.
258. Ruchsow, M., Herrnberger, B., Wiesend, C., Gron, G., Spitzer, M. and Kiefer, M. (2004) The effect of erroneous responses on response monitoring in patients with major depressive disorder: A study with event-related potentials. Psychophysiology, 41, pp. 833-840.
259. Russo-Neustadt, A., Ramirez, R. and Kesslak, JP (2001) Physical activity-antidepressant treatment combination: Impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res, 120, pp. 87-95.
260. Rutter, M. (1984) Psychopathology and development: II. Childhood experiences and personality development. Aust NZ J Psychiatry, 18, pp. 314-327.
261. Salas, MA, Evans, SW, Levell, MJ and Whicher, JT (1990) Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells. Clin Exp Immunol, 79, pp. 470-473.
262. Santarelli, L., Saxe, M. and Gross, C. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301, pp. 805-809.
263. Sargent, PA, Kjaer, KH and Bench, CJ (2000) Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry, 57, pp. 174-180.
264. Scharfman, HE and Maclusky, NJ (2005) Similarities between actions of estrogen and BDNF in the hippocampus: Coincidence or clue?. Trends Neurosci, 28, pp. 79-85.
265. Schatzberg, AF, Posener, JA, DeBattista, C., Kalehzan, BM, Rothschild, AJ and Shear, PK (2000) Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. Am J Psychiatry, 157, pp. 1095-1100.
266. Schwarcz, R. and Pellicciari, R. (2002) Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther, 303, pp. 1-10.
267. Segal, RA and Greenberg, ME (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci, 19, pp. 463-489.
268. Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A. and Kirchner, H. (1996) Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand, 94, pp. 198-204.
269. Sen, S., Nesse, RM and Stoltenberg, SF (2003) A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology, 28, pp. 397-401.
270. Serretti, A., Lorenzi, C. and Cusin, C. (2003) SSRIs antidepressant activity is influenced by G beta 3 variants. Eur Neuropsychopharmacol, 13, pp. 117-122.
271. Sheline, YI, Gado, MH and Kraemer, HC (2003) Untreated depression and hippocampal volume loss. Am J Psychiatry, 160, pp. 1516-1518.
272. Sheline, YI, Sanghavi, M., Mintun, MA and Gado, MH (1999) Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci, 19, pp. 5034-5043.
273. Shimizu, E., Hashimoto, K. and Okamura, N. (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry, 54, pp. 70-75.
274. Shirayama, Y., Chen, AC, Nakagawa, S., Russell, DS and Duman, RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci, 22, pp. 3251-3261.
275. Siblerud, RL, Motl, J. and Kienholz, E. (1994) Psychometric evidence that mercury from silver dental fillings may be an etiological factor in depression, excessive anger, and anxiety. Psychol Rep, 74, pp. 67-80.
276. Simopoulos, AP, Leaf, A. and Salem Jr, N. (1999) Workshop on the Essentiality of and Recommended Dietary Intakes for Omega-6 and Omega-3 Fatty Acids. J Am Coll Nutr, 18, pp. 487-489.
277. Siuciak, JA, Lewis, DR, Wiegand, SJ and Lindsay, RM (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav, 56, pp. 131-137.
278. Sklar, P., Gabriel, SB and McInnis, MG (2002) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry, 7, pp. 579-593.
279. Sluzewska, A., Rybakowski, JK, Laciak, M., Mackiewicz, A., Sobieska, M. and Wiktorowicz, K. (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci, 762, pp. 474-476.
280. Sluzewska, A., Rybakowski, J. and Bosmans, E. (1996) Indicators of immune activation in major depression. Psychiatry Res, 64, pp. 161-167.
281. Smith Jr, DL (1978) Mental effects of mercury poisoning. South Med J, 71, pp. 904-905.
282. Smith, MA, Makino, S., Kvetnansky, R. and Post, RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci, 15, pp. 1768-1777.
283. Song, C., Lin, A. and Bonaccorso, S. (1998) The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord, 49, pp. 211-219.
284. Srikantaiah, MV and Radhakrishnan, AN (1970) Studies on the metabolism of vitamin B6 in the small intestine. 3. Purification and properties of monkey intestinal pyridoxal kinase. Indian J Biochem, 7, pp. 151-156.
285. Stefanovic, V., Vlahovic, P., Savic, V., Ilic, S. and Mitic-Zlatkovic, M. (1998) Kidney ectopeptidases in gentamicin and mercuric chloride-induced acute renal failure. Cell Physiol Biochem, 8, pp. 278-284.
286. Stockmeier, CA, Dilley, GE, Shapiro, LA, Overholser, JC, Thompson, PA and Meltzer, HY (1997) Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology, 16, pp. 162-173.
287. Stockmeier, CA, Shapiro, LA, Dilley, GE, Kolli, TN, Friedman, L. and Rajkowska, G. (1998) Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci, 18, pp. 7394-7401.
288. Stübner, S., Schon, T. and Padberg, F. (1999) Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: No alteration of soluble gp130. Neurosci Lett, 259, pp. 145-148.
289. Surtees, R., Heales, S. and Bowron, A. (1994) Association of cerebrospinal fluid deficiency of 5-methyltetrahydrofolate, but not S-adenosylmethionine, with reduced concentrations of the acid metabolites of 5-hydroxytryptamine and dopamine. Clin Sci (Lond), 86, pp. 697-702.
290. Sutton, S., Braren, M., Zubin, J. and John, ER (1965) Evoked-potential correlates of stimulus uncertainty. Science, 150, pp. 1187-1188.
291. Svenningsson, P., Chergui, K. and Rachleff, I. (2006) Alterations in 5-HT1B receptor function by p11 in depression-like states. Science, 311, pp. 77-80.
292. Sweeney, JA, Kmiec, JA and Kupfer, DJ (2000) Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry, 48, pp. 674-684.
293. Syvalähti, E., Eskola, J., Ruuskanen, O. and Laine, T. (1985) Nonsuppression of cortisol in depression and immune function. Prog Neuropsychopharmacol Biol Psychiatry, 9, pp. 413-422.
294. Tancer, ME, Brown, TM and Evans, DL (1990) Impaired effortful cognition in depression. Psychiatry Res, 31, pp. 161-168.
295. Taylor, MJ, Carney, SM, Goodwin, GM and Geddes, JR (2004) Folate for depressive disorders: Systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol, 18, pp. 251-256.
296. Tham, A., Engelbrektson, K., Mathe, AA, Johnson, L., Olsson, E. and Aberg-Wistedt, A. (1997) Impaired neuropsychological performance in euthymic patients with recurring mood disorders. J Clin Psychiatry, 58, pp. 26-29.
297. Thoenen, H. (1995) Neurotrophins and neuronal plasticity. Science, 270, pp. 593-598.
298. Tiemeier, H., van Tuijl, HR, Hofman, A., Meijer, J., Kiliaan, AJ and Breteler, MM (2002) Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry, 159, pp. 2099-2101.
299. Tolmunen, T., Hintikka, J. and Ruusunen, A. (2004) Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother Psychosom, 73, pp. 334-339.
300. Trentani, A., Kuipers, SD, Horst, GJ Ter and Boer, JA Den (2002) Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: Implications for stress-related cortical pathology?. Eur J Neurosci, 15, pp. 1681-1691.
301. Tsai, SJ, Hong, CJ, Yu, YW, Chen, TJ, Wang, YC and Lin, WK (2004) Association study of serotonin 1B receptor (A-161T) genetic polymorphism and suicidal behaviors and response to fluoxetine in major depressive disorder. Neuropsychobiology, 50, pp. 235-238.
302. Tsai, SJ, Hong, CJ and Hsu, CC (1999) Serotonin-2A receptor polymorphism (102T/C) in mood disorders. Psychiatry Res, 87, pp. 233-237.
303. Turecki, G., Sequeira, A. and Gingras, Y. (2003) Suicide and serotonin: study of variation at seven serotonin receptor genes in suicide completers. Am J Med Genet B Neuropsychiatr Genet, 118, pp. 36-40.
304. Tyler, WJ, Alonso, M., Bramham, CR and Pozzo-Miller, LD (2002) From acquisition to consolidation: On the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem, 9, pp. 224-237.
305. Ullian, EM, Sapperstein, SK, Christopherson, KS and Barres, BA (2001) Control of synapse number by glia. Science, 291, pp. 657-661.
306. Urretavizcaya, M., Moreno, I. and Benlloch, L. (2003) Auditory event-related potentials in 50 melancholic patients: Increased N100, N200 and P300 latencies and diminished P300 amplitude. J Affect Disord, 74, pp. 293-297.
307. van der Hart, MG, Czeh, B. and de Biurrun, G. (2002) Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Mol Psychiatry, 7, pp. 933-941.
308. Villafuerte, SM, Del-Favero, J. and Adolfsson, R. (2002) Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression. Am J Med Genet, 114, pp. 222-226.
309. Vollmayr, B., Simonis, C., Weber, S., Gass, P. and Henn, F. (2003) Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol Psychiatry, 54, pp. 1035-1040.
310. Walther, DJ and Bader, M. (2003) A unique central tryptophan hydroxylase isoform. Biochemical Pharmacology, 66, pp. 1673-1680.
311. Walther, DJ, Peter, JU and Bashammakh, S. (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 299, p. 76.
312. Wang, J. and Dunn, AJ (1998) Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem Int, 33, pp. 143-154.
313. Wang, J. and Dunn, AJ. (1999) The role of interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1 beta. Brain Res, 815, pp. 337-348.
314. Weiss, G., Murr, C. and Zoller, H. (1999) Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol, 116, pp. 435-440.
315. Wesson, VA, Levitt, AJ and Joffe, RT (1994) Change in folate status with antidepressant treatment. Psychiatry Res, 53, pp. 313-322.
316. Willeit, M., Praschak-Rieder, N. and Zill, P. (2003) C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder. Biol Psychiatry, 54, pp. 682-686.
317. Williams, AL, Cotter, A., Sabina, A., Girard, C., Goodman, J. and Katz, DL (2005) The role for vitamin B-6 as treatment for depression: A systematic review. Fam Pract, 22, pp. 532-537.
318. Wolfersdorf, M. and Konig, F. (1995) Serum folic acid and vitamin B12 in depressed inpatients. A study of serum folic acid with radioimmunoassay in 121 depressed inpatients]. Psychiatr Prax, 22, pp. 162-164.
319. Wolfersdorf, M., Keller, F., Maier, V., Froscher, W. and Kaschka, WP (1995) Red-cell and serum folate levels in depressed inpatients who commit violent suicide: A comparison with control groups. Pharmacopsychiatry, 28, pp. 77-79.
320. Wolters, M., Strohle, A. and Hahn, A. (2004) Age-associated changes in the metabolism of vitamin B(12) and folic acid: Prevalence, aetiopathogenesis and pathophysiological consequences]. Z Gerontol Geriatr, 37, pp. 109-135.
321. Buchsbaum, MS and Gillin, JC (1999) Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry, 156, pp. 1149-1158.
322. Yamada, S., Yamamoto, M., Ozawa, H., Riederer, P. and Saito, T. (2003) Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J Neural Transm, 110, pp. 671-680.
323. Young, SN. (1993) The use of diet and dietary components in the study of factors controlling affect in humans: A review. J Psychiatry Neurosci, 18, pp. 235-244.
324. Yu, YW, Chen, TJ, Wang, YC, Liou, YJ, Hong, CJ and Tsai, SJ (2003) Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology, 47, pp. 137-140.
325. Zhang, HY, Ishigaki, T. and Tani, K. (1997) Serotonin2A receptor gene polymorphism in mood disorders. Biol Psychiatry, 41, pp. 768-773.
326. Zhou, D., Kusnecov, AW, Shurin, MR, DePaoli, M. and Rabin, BS (1993) Exposure to physical and psychological stressors elevates plasma interleukin 6: Relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology, 133, pp. 2523-2530.
327. Zill, P., Baghai, TC and Zwanzger, P. (2000) Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport, 11, pp. 1893-1897.
328. Zubenko, GS, Hughes 3rd, HB and Stiffler, JS (2003) Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol Psychiatry, 8, pp. 611-618.